No. 25-6751

Jeffrey W. Young, Jr. v. United States

Lower Court: Sixth Circuit
Docketed: 2026-02-06
Status: Pending
Type: IFP
IFP
Tags: appellate-review controlled-substances drug-distribution medical-practice regulatory-definition subject-matter-jurisdiction
Key Terms:
AdministrativeLaw Environmental JusticiabilityDoctri
Latest Conference: N/A
Question Presented (from Petition)

Whether the lower federal court lacked subject matter jurisdiction over the defendant, who was an authorized practitioner with the authority to administer drugs as part of his practice at the time of the alleged offense, due to the lower court's improper reliance on regulatory definitions and testimony outside of the U.S. Code that regulates the distribution of drugs in the practice of medicine?

In other words, did this Court's holding in Loper foreclose the Attorney General's reliance on a CFR to define what constituted a legitimate prescription versus "illegal drug dealing" when the defendant was licensed to administer the controlled substances under the Controlled Substance Act?

Question Presented (AI Summary)

Whether the lower federal court lacked subject matter jurisdiction over the defendant due to improper reliance on regulatory definitions outside the U.S. Code that regulate drug distribution in medical practice?

Docket Entries

2026-02-13
Waiver of United States of right to respond submitted.
2026-01-23
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due March 9, 2026)

Attorneys

Jeffrey W. Young, Jr.
Claiborne Hambrick FergusonThe Ferguson McNeil Law Firm, P.A., Petitioner
United States
D. John SauerSolicitor General, Respondent